or Try an Advanced Search...

    Innogenetics Stocks List

    Symbol Grade Name % Change
    MYNZ F Mainz Biomed B.V. -6.21
    LH B Laboratory Corporation of America Holdings 0.99
    View As Page of Charts
    Related Industries: Diagnostics & Research
    Related Stock Lists: Diagnostic Tests Medical Test Allergy Blood Test Cancer Cancer Screening Cardiovascular Disease Clinical Medicine Colorectal Cancer Diagnosis Of Hiv/Aids Disease Genotyping HCV HIV HIV/Aids Infectious Diseases Life Sciences Medical Genetics Medical Laboratory Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Innogenetics stocks.

    Symbol Grade Name Weight
    CAMX A The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF 4.59
    EDOC C Global X Telemedicine & Digital Health ETF 4.28
    LSAT A LeaderShares AlphaFactor Tactical Focused ETF 3.5
    IHF D iShares U.S. Health Care Providers ETF 3.38
    XHS D SPDR S&P Health Care Services ETF 2.26
    View all Innogenetics ETFs...
    Compare ETFs
    Compare CAMX to EDOC Compare EDOC to LSAT Compare LSAT to XHS

        Innogenetics Stocks Recent News

        Date Stock Title
        Nov 19 LH Labcorp gets new finance chief
        Nov 19 LH Labcorp CFO Glenn Eisenberg Announces Plans to Retire
        Nov 15 LH Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
        Related Industries: Diagnostics & Research
        Related Stock Lists: Diagnostic Tests Medical Test Allergy Blood Test Cancer Cancer Screening Cardiovascular Disease Clinical Medicine Colorectal Cancer Diagnosis Of Hiv/Aids Disease Genotyping HCV HIV HIV/Aids Infectious Diseases Life Sciences Medical Genetics Medical Laboratory Medicine
        Innogenetics

        Innogenetics N.V. (now Fujirebio Europe N.V.) is an international in vitro diagnostics (IVD) company, with headquarters in Ghent, Belgium. The company develops and markets IVD testing solutions from specialized manual testing to fully automated routine testing that cover areas such as infectious diseases, oncology, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bone. The company was acquired in September 2010 by Japanese Fujirebio Inc., part of Miraca Holdings Inc., and changed name to Fujirebio Europe on October 1, 2013. The CEO of Fujirebio Europe N.V. is Christiaan De Wilde.

        More about Innogenetics
        Browse All Tags